Physician

Caroline West Laggis, MD

According to 2025 Medicare claims, Caroline Laggis, MD (NPI: 1295197853) practices dermatology in the Grand Junction, CO market, with the plurality of this provider's patient population coming from Mesa, CO. This provider's primary affiliated billing organization is MOUNTAIN WEST DERMATOLOGY, PC (NPI: 1497871073; TIN: 840611546) and primary practice location at 81501-8801. Laggis is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Laggis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 831 traditional Medicare patients, billed 6,274 HCPCS/CPT codes, and received $206,384 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,427 prescription claims across 493 beneficiaries totaling $1,151,162 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 22 records totaling $494. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $70,423 to $206,384. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,154 to $1,151,162. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$103K$207K2020 Medicare payment: $70,423 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $126,016 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $200,813 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $206,598 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $206,384 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20203611,874$70,423
20215673,961$126,016
20227576,441$200,813
20237777,524$206,598
20248316,274$206,384

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$576K$1.2M2018 Drug cost: $1,154 (USD; Tot_Drug_Cst)2019 Drug cost: $4,027 (USD; Tot_Drug_Cst)2020 Drug cost: $212,304 (USD; Tot_Drug_Cst)2021 Drug cost: $326,112 (USD; Tot_Drug_Cst)2022 Drug cost: $697,736 (USD; Tot_Drug_Cst)2023 Drug cost: $1,130,873 (USD; Tot_Drug_Cst)2024 Drug cost: $1,151,162 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182232$1,154
201960119$4,027
2020141266$212,304
2021266558$326,112
2022394950$697,736
20233961,117$1,130,873
20244931,427$1,151,162

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more256316$88
11102Biopsy of related skin growth, first growth224247$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more560780$60
17000Destruction of precancer skin growth, 1 growth415565$39
17003Destruction of precancer skin growth, 2-14 growths2931,628$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa141,064$286,396
Humira(Cf) PenAdalimumab21609$181,176
Cosentyx (2 Syringes)Secukinumab11308$94,255
Dupixent SyringeDupilumab12336$44,453
Clobetasol PropionateClobetasol Propionate2335,878$11,074

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$494Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Caroline West Laggis, MD?

Tedicare shows public-source Medicare data for Caroline West Laggis, MD (NPI 1295197853), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Caroline West Laggis, MD have ACO affiliation data?

Caroline West Laggis, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Caroline West Laggis, MD?

Caroline West Laggis, MD is linked to MOUNTAIN WEST DERMATOLOGY, PC (billing NPI 1497871073) in the available physician profile data.

Does Caroline West Laggis, MD have Open Payments data?

Caroline West Laggis, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.